快讯: 2011国际临床医学SCI论文写作与发表策略研讨会圆满成功

2011-03-27 MedSci MedSci原创

??? 2011国际临床医学SCI论文写作与发表策略研讨会,由MedSci主办,生物谷承办的盛会,刚刚圆满闭幕。会议特邀放射领域顶级期刊Radiology主编Schweitzer和Neuroimaging主编Thomas Dierks分享了临床医学领域文章的写作,投稿和发表的经验,以及碰到的常见问题,两位大师从国际的视角分享了中国作者文章的主要存在的问题。 ??? 同时,会议还邀请了上海放射学会

    2011国际临床医学SCI论文写作与发表策略研讨会,由MedSci主办,生物谷承办的盛会,刚刚圆满闭幕。会议特邀放射领域顶级期刊Radiology主编Schweitzer和Neuroimaging主编Thomas Dierks分享了临床医学领域文章的写作,投稿和发表的经验,以及碰到的常见问题,两位大师从国际的视角分享了中国作者文章的主要存在的问题。

    同时,会议还邀请了上海放射学会主任委员,上海影像研究所所长李明华教授,上海市第十人民医院副院长陈英升教授,北京大学临床研究所副所长、北京大学第一医院医学统计室主任姚晨教授进行了精彩的演讲。

    有来自全国各地近200人参与了此次盛会,同时还举行了独树一帜的Panel discussion,精选10位作者与三位外籍专家面对面交流,直接文章的要害。不少作者表示,此行十分有收获。

    稍后,我们会有详细报道。

会议网站:http://www.bioon.com/z/rad-sci/ 

附:

背景介绍:

为加快广大临床医生和科研工作者的临床发现与科研成果转化, 与国际医学学术接轨,MedSci联合国际权威杂志Radiology、Neuroimaging主编以及多位著名专家,于3月26-27号在上海举办SCI论文写作与发表策略研讨会,就临床医学论文课题设计、医学科研常用统计方法、基金申请技巧、SCI论文写作技巧与发表策略等关键环节作深入剖析。此次研讨会将对部分收到的论文进行“一对一“点评。此次会议是一次非常难得的与世界权威杂志医学期刊主编及资深专家交流和学习的机会,我们诚挚邀请全国同仁参加此次大会!

本次论坛特色:

一流编辑:论坛将邀请世界著名期刊主编进行授课,教授以及如何有效设计与组织临床科研成果,并使其成果与国际同行交流。

内容实用:针对临床科研研究进展,从而为临床科研选题,研究方案设计,临床科研成果的写作发表进行探讨,具有很强的实用性。

形式独特:会议有著名专家的讲座,同时也有现场座谈和临床科研成果的点评与总结,现场剖析临床科研的闪光点。

现场点评:本次论坛,会员可以会前投稿,组委会将请国内外资深专家对文章进行质量快速评审,部分文章将有机会获得专家的当面“一对一”点评。

会议时间:2011年3月25日--3月27日

会议地点:上海医学院路复旦医学院明道楼(地址:上海市徐汇区医学院路138号)

主办单位简介:

Radiology

Published regularly since 1923 by the Radiological Society of North America (RSNA), Radiology has long been recognized as the authoritative reference for the most current, clinically relevant, and highest quality research in the field of radiology. Each month the journal publishes approximately 300 pages of peer-reviewed original research, authoritative reviews, well-balanced commentary on significant articles, and expert opinion on new techniques and technologies.

Neuroimaging

The Neuroimaging section of Psychiatry Research publishes manuscripts on positron emission tomography, magnetic resonance imaging, computerized electroencephalographic topography, regional cerebral blood flow, computed tomography, magnetoencephalography, autoradiography, post-mortem regional analyses, and other imaging techniques. Reports concerning results in psychiatric disorders, dementias, and the effects of behaviorial tasks and pharmacological treatments are featured. We also invite manuscripts on the methods of obtaining images and computer processing of the images themselves. Selected case reports are also published.

MedSci

MedSci是中国专业科研与临床学术服务领先提供商,也是中国科研与临床教育、培训的拓展者。汇聚来自全球著名高校的300多名医药、生物专业博士团队的雄厚学术力量, MedSci致力于搭建中国与世界医学、生物科研互动的桥梁,为中国科研与临床学术研究提供专业的技术指导与学术支持。多年来,MedSci专注于医学生物领域,已服务70多个细分学科的两万多名客户,成功协助他们开展科学研究,并帮助其在第一时间将临床发现与科研成果展现给世界的同行们。目前,MedSci 主要提供SCI学术论文发表支持,基金申请咨询/标书修改,科研方案设计咨询,实验技术指导,资料统计挖掘,论文写作指导,科研教育培训,学术会议支持,产品学术推广等。 MedSci将凭借独特的学术背景和技术优势为客户提供专业的“一站式”科研学术服务。

支持单位简介:

复旦大学生物医学研究院(Institutes of Biomedical Sciences, 简称IBS)

始建于2004年3月,是国家985二期工程建设的科技创新平台。研究院的宗旨是:“健康上海人,欢乐中国人”。研究院遵循“章鱼模式”发展,建设人才聚集高地、领衔大项目高地和做一流研究高地。研究院以“转化医学”为目标,积极推动复旦大学生命科学与医学的有机结合,建立基础科学与临床需求的紧密联系。 研究院的院训是“铭诚、卓毅、协作、拓新”。 生物医学研究院实行平台管理委员会领导下的首席科学家负责制,管理上遵循国际通用的PI管理模式。研究方向以国家中长期科技规划以及国家、上海市的经济建设和社会发展设计组织项目申请和团队建设为出发点,设立的主要研究方向包括:疾病系统生物学、出生缺陷与发育生物学、疾病发生的分子机制、创新药物和结构生物学等。研究院现拥有院士7名,全时引进PI 20人,分时引进PI 8人,双聘PI 43人,研究人员20余名,工程技术人员20余名。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2015-09-27 hugo

    Help, I've been informed and I can't become ignrnaot.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2014-01-19 lmz

    挺有收获,很不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2012-03-09 kcb069
  4. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=37469, encodeId=0f7b3e469ef, content=Help, I've been informed and I can't become ignrnaot., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hugo, createdTime=Sun Sep 27 09:37:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6892, encodeId=cf79689283, content=挺有收获,很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=449c94210, createdName=lmz, createdTime=Sun Jan 19 00:08:00 CST 2014, time=2014-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994648, encodeId=7ce919946483c, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Fri Mar 09 00:45:00 CST 2012, time=2012-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279532, encodeId=d14112e9532df, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404427, encodeId=7cef140442e9a, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Tue Mar 29 05:45:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096, encodeId=dbc020961c, content=参加了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=郭, createdTime=Sun Mar 27 23:28:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2011-03-27

    参加了,不错不错

    0

相关资讯

MedSci新增会议频道

   不少会员来信,希望MedSci提供一站式的学术服务,包括学术会议的报道。MedSci作为综合性科研学术服务平台,已成功在国内外举办超过20场大型学术会议。包括近期在北京连续11场的大型医院讲座会,以及在北京,上海,武汉,天津,杭州,南京,成都,重庆,西安等进行一系列基于临床科研设计,资料收集整理,临床Idea的获取,科研严谨性训练,论文资料整理,医学统计学处理,

MedSci“临床科研中国行”全国巡回讲座(四川、重庆站)正在进行中

        MedSci“临床科研中国行”全国巡回讲座(四川、重庆站)正在进行。本次讲座的主要内容有:1. 临床SCI论文选题;2. SCI论文发表支持与期刊选择技巧;3. 临床资料如何转化成SCI文章;4. 从REVIEWER角度看SCI文章。讲座吸引了大批MedSci新老客户的参与,MedSci资深编辑将MedSci处理

预告:MedSci“临床科研中国行”全国巡回讲座(南京军区南京总医院)

        MedSci是综合临床医学和科研学术服务平台,致力于从事医学临床和科研的教育、培训和医学学术服务指导,全面提升中国医学和科研学术水平,全面对接中国和国际最新研究成果。        MedSci将于11月23日在南京军区南京总医院举办医学临床科

第一届国际临床医学SCI论文写作与发表策略研讨论会

背景介绍:       随着计算机技术的飞速发展,与计算机技术密切相关的影像技术也日新月异,医学影像学已成为医学领域发展最快的学科之一。新型影像学诊疗手段,如PET/CT,MRI,CT , PET/MR等发展速度惊人。各类超高速扫描,超宽探测器,超高分辨率成像,辐射剂量不断降低,应用软件的不断创新,CT/MR/DSA/PET图像的融合